文献速递神经肿瘤

松果体区肿瘤全切与长期生存:赫尔辛基神经外科经验

Extent of Resection and Long-Term Survival of Pineal Region Tumors in Helsinki Neurosurgery.
PubMed 文献 · World Neurosurg · 2019-07-30

该回顾性研究分析了1997至2015年间在赫尔辛基神经外科手术治疗的76例松果体区肿瘤,平均随访125±105个月,生存率为62%,疾病相关死亡14例(18.4%)。完全显微手术切除与更好的无瘤生存和长期生存相关,但弥漫性胶质瘤除外。

要点

  • 完全显微手术切除与松果体区肿瘤更好的长期生存相关。
  • 疾病相关死亡14例(18.4%),其中10例发生在术后5年内。
  • 弥漫性胶质瘤患者术后5年内死亡率高,与切除程度无关。

核心结论

  • 在多学科管理背景下,完全显微手术切除与松果体区肿瘤的良好生存和低死亡率相关。

研究设计与样本

  • 回顾性研究,纳入1997年至2015年间在赫尔辛基神经外科手术治疗的76例松果体区肿瘤,随访至2018年7月。

主要发现

  • 平均随访125±105个月(范围0-588个月),生存率为62%,疾病相关死亡14例(18.4%)。
  • 截至2018年7月,29例患者死亡,其中2例死于术后迟发性丘脑梗死,12例死于疾病进展,15例为非疾病相关死亡。
  • 14例疾病相关死亡中10例发生在随访前5年:5例弥漫性胶质瘤、3例生殖细胞肿瘤、1例II-III级松果体实质肿瘤中间分化、1例脑膜瘤。
  • 完全显微手术切除与更好的无瘤生存和长期生存相关,但弥漫性胶质瘤除外。

临床怎么用

  • 对于松果体区肿瘤,应争取完全显微手术切除以改善长期生存。
  • 术后需多学科管理,并关注弥漫性胶质瘤患者的高早期死亡风险。

局限性

  • 回顾性研究,样本量有限(76例),仅1例长期随访失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pineal region tumors represent challenging surgical lesions with wide ranges of survival reported in different surgical series. In this article, we emphasize the role of complete microsurgical resection (CMR) to obtain a favorable long-term outcome of pineal region tumors. METHODS: We report a retrospective study of pineal region tumors operated on in Helsinki Neurosurgery between 1997 and 2015. Information was obtained from the hospital records, and an evaluation of the Finnish population register was conducted in July 2018 to determine the current status of the patients. RESULTS: A total of 76 pineal region tumors were operated on. The survival was 62% at a mean follow-up of 125 ± 105 months (range, 0-588 months), and the disease-related mortality was limited to 14 patients (18.4%). Up to July 2018, 29 patients had died. Two patients died 1 and 3 months after surgery of delayed thalamic infarctions, 12 patients of disease progression, and 15 had non-disease-related deaths. Only 1 patient was lost in the long-term follow-up. Ten of 14 disease-related deaths occurred during the first 5 years of follow-up: 5 diffuse gliomas, 3 germ cell tumors, 1 grade II-III pineal parenchymal tumor of intermediate differentiation, and 1 meningioma. CMR was linked to better tumor-free survival and long-term survival, with the exception of diffuse gliomas. CONCLUSIONS: CMR, in the setting of a multidisciplinary management of pineal region tumors, correlates with favorable survival and with minimal mortality. Surgically treated grade II-IV gliomas constitute a particular group with high mortality within the first 5 years independently of the microsurgical resection.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Choque-Velasquez J, Resendiz-Nieves J, Jahromi BR, et al. Extent of Resection and Long-Term Survival of Pineal Region Tumors in Helsinki Neurosurgery. World Neurosurg. 2019. PMID: 31369883. doi:10.1016/j.wneu.2019.07.169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。